chrisvoncsefalvay/vaers-outcomes huggingface dataset:
C-O was working in the vaccine clinic today assisting in scheduling customers. She obtained her second COVID-19 vaccine at approximately noon today. At 1330 she approached my desk with c/o left sided abdominal pain, scratchy throat, voice changes, and feeling tachycardic.  Denied hx. Anaphylaxis or hx. Adverse reactions to any vaccines.  She was given 50mg of diphenhydramine at 1332. At this time her pulse was 125, oxygen saturation 97%, unable to obtain BP due to small cuff size available. Med rec completed. Medical history taken, no contraindications to COVID-19 vaccine noted.  She was advised to lay down during this time and reported feeling a little better within 30 minutes of taking diphenhydramine, though noted onset of headache starting and mentions hx migraines. By 1409 her pulse was reduced to 98 bmp. 1434 C-O reported feeling a little lightheaded upon standing from laying, pulse 92 and oxygen saturation 98.  C-O was advised to sit and dangle for a time and then she decided to lay back down.  At 1443 C-O reported improvement in symptoms except now had headache and drowsiness, BP 118/78, Pulse 90, oxygen saturation 98. C-O requested to leave to coordinate pickup from relative and I felt she was stable and did not require further treatment or monitoring at this time so agreed she could leave
Rash/hives on neck, chest, arms and lower legs ........very itchy!
Information has been received from a registered nurse concerning a 13 year old female who was vaccinated with the first dose of Gardasil, intramuscularly (IM) on 16-FEB-2007, the second dose of Gardasil on 19-APR-2007, both lot numbers 654702/0011U, with no adverse reaction. She received the third dose of Gardasil on 21-AUG-2007, lot number 658222/0927U. "Four days later", on 26-AUG-2007, she had a seizure for 3 1/2 minutes. The patient also complained of headaches within a short duration after the third dose of Gardasil. It is not known what treatment or interventions were given in the ambulance on transport to the Emergency Room (ER). She was seen and examined in the ER. All lab tests, computerized tomography (CT) scan, and neck x-ray were normal. The patient saw a Neurologist on 27-AUG-2007 with no neurological findings for seizure. As of 28-AUG-2007, the patient had recovered from the headaches and the seizure. Upon internal review, seizure was determined to be an other important medical event. This is one of several reports from the same source/siblings. Additional information has been requested.
shingles; postherpetic neuralgia; This spontaneous report was received from a lawyer and a patient of unknown age and gender regarding a case in litigation on 02-MAR-2022. The patient's concurrent conditions, medical history, drug reactions or allergies were not reported. In or around November 2014 the patient was administered with Zoster Vaccine Live (ZOSTAVAX) (dose, lot #, expiration date, route of administration, and anatomical location was not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving Zoster Vaccine Live (ZOSTAVAX), the patient suffered shingles (herpes zoster), and post herpetic neuralgia. As a direct and proximate result of using Zoster Vaccine Live (ZOSTAVAX), the patient's symptoms had resulted in physical limitations not present prior using Zoster Vaccine Live (ZOSTAVAX). Also, experienced mental and emotional distress due to resulting physical limitations and seriousness of patient's conditions. As a result of the manufacture, marketing, advertising, promotion, distribution and or sale of Zoster Vaccine Live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence the patient suffered serious, progressive, permanent and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. At the reporting time, the outcome of the event herpes zoster and post herpetic neuralgia was considered as not recovered. The reporter considered the events to be related to Zoster Vaccine Live (ZOSTAVAX).
Vomiting, clear liquid, no fever, chills or diarrhea. Was in ER twice and then encouraged to go to another hospital where he was in ER.
10 MINUTE GENERALIZED SEIZURE ASSOCIATED WITH A FEVER OF 103 AT 4 AM ON 8/10/05, 9 DAYS AFTER MMR GIVEN ON 8/1/05.
On 2/19/2021 at about 5:00PM, I had hard thigh cramps. They were just in my thighs at first, but they then spread to my stomach and the rest of my legs afterwards. I rubbed Icy Hot on them and then went to bed about 7:30PM. The Icy Hot relieved the cramps enough that I was able to get to sleep. On 2/20/2021 at between 2:00-4:00AM, I had severe dry heaves. The dry heaves lasted for over an hour. I was so exhausted that I stayed in bed. I also had bouts of severe diarrhea and my stomach was so inflamed by the dry heaves that it was very painful and I was bloated. On 2/21/2021, my stomach muscles hurt so badly I could hardly get up. I was also very weak. I took ibuprofen and called a nurse, who urged me to go to the nearest hospital. I then went to emergency room, and I was hospitalized until 2/26/2021. I was told that I had pneumonia in both lungs. After I was released, I was on antibiotics for a week, and I was fine afterwards.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The patient was vaccinated with one dose of 0.65 ml ZOSTAVAX (lot number 672429/1606AA< expiration date 13-JAN-2013) (expiration date 30-APR-2012 as reported) subcutaneously on 16-MAY-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse effects reported. It was unspecified if the patient had sought medical attention. This is one of several reports received from the same source. Additional information is not expected.
Initial and follow up information has been received from a physician concerning a 37 year old white female nurse with no known drug allergies and slight anaemia who on Mar 7 2005 was vaccinated SC with a dose of Mumps virus vaccine live (Jeryl Lynn) (lot 650129/0770P). It was noted that there were no other vaccines administered on that day. On Mar 17 2005 the patient experienced fatigue and general malaise. On Mar 18 2005 the patient saw her doctor and experienced a stiff neck, a severe headache described as felt like it was going to explode and she developed a fever of 101F. There was no illness at the time of vaccination. On Mar 2005 the patient's fever broke. On Mar 21 2005, the patient saw her doctor again. The physician reported that sometime on Mar 21 2005, the patient recovered. Additional information is not expected.
abdominal cramping  x1day, vomiting, diarrhea x1day , upset stomach unable to eat  x3days, weakness x2days, fatigue x4days, fever 102.6 x 1day, chills x1day.
6 Hours after injection pain radiating from left side of neck to fingertips left arm swollen/arm area from left shoulder/to elbow. Area from left shoulder to elbow red/ especially at injection site. Still have sharp pain at injection site.
severe sz; Per follow-up dated 9/11/00, the pt continues to have seizures daily.
Systemic: Headache-Severe, Additional Details: Patient experienced extreme migraines from first COVID pfizer shot at her work at her senoir living facility. Could not get the lot number before she left but I believe she has it on her card
Pt described painful uncomfortable weird pain at time of injection lasting approximately 10 seconds. Pt states now has constant pain with movement of left arm since injection.
A 35 year old female patient received a dose of Ipol and a dose of Meningococcal vaccine on 26/Jul/2006 fro travel purpose. The lot numbers, routes and sites of administration were not reported. The following day, the patient presented to an urgent care facility with a headache and a fever of 103 degrees Fahrenheit. At the time of this report the patient had not recovered from the events. Follow up information received on 03 November 2006 from a health care professional. Ipol, lot number 904030, was administered in the left deltoid. Menactra, (previously reported as meningococcal vaccine), lot number U1978AA, was administered in the right deltoid. The patient experienced fever, headache, chills, and was dizzy for four days. A HCG test on 25 July 2006 was negative. The patient fully recovered.
I wAs clear At TiME oF shot. BROKE out iN RASh and BlisteRs. Went BAck to store ANd showed Myself To The Pharmacy Dr Lady. She and Another Pharmacy LAdy sAid They hAd NeveR seen Anything Like it. I had 2 precription to have filled, So I Stoped At Pharmacy, Had my scripts filled and got my flue shot while I was there. It was apx 3:30 pm in evening. Felt Fine. Woke up at 6 AM got up and noticed I was Broke out all over my face and neck with Blisters and a rash. So I got ready for church and when I got home, I went straight back to pharmacy. The LAdy pharmacy Looks at me and said I've never seen anyone look this bad. She took me down the Isles and got me Diphenhydramine HCI 25 mg and 1% HydRoCoRtsone ANtipRURitic CREAM. 6 DAy LAtter my FAce, Neck, BrEAST is Finally clearing up. I'm not Al the WAy CleAR yet But Alot clearer This is 8 DAy LAteR. Thank You for You're Concern.
Administration of Pfizer Bivalent child dose (age 5-11).  The vaccine was not diluted prior to administration.  Patient received 0.2ml however there was no dilution.   Spoke to mother, she said daughter was okay with no adverse reactions as of yet.  No tenderness, fever, arm pain.  Vaccine was administered at 12:04pm on left arm.  Spoke to mom at 2:09pm to let her know of the discovery.  We will follow up with parents in a couple days to see if patient is ok and or is having any reactions.
Erythema, swelling, and warm to the touch noted at vaccine injection site (2 days after injection). Abx and 3-day course of steroids given.
BODY ACHES, FATIGUE, DIARRHEA, AND ALTERED BALANCE
Two days after the vaccine was given, Patient started to have neck pain. Then it began to burn in upper arm to elbow. Her arm swometimes feels heavy and aches. Middle 3 fingers tingle
Patient was given pfizer shot at 5:25pm on 8/24/21 and within 5 minutes patient experience syncope symtoms( lightheadedness and sweating) at 5:30pm.  I helped patient to lay down on the ground and elevate his feet. I stayed with the patient to monitor his condition.  Patient was super nervous about the shot and he was always anxious with needle.  According to the patient, he always have syncope symptoms when getting any type of vaccine or blood drawn.  We had patient lay down until 5:50pm when he feels much better so we have him sit until 6:10pm when he recovered completely and ready to go home. Per patient, he has not eat anything and coupled with anxiety, it probably lead to the reaction.
Patient experienced shortness of breath, shoulder rash, fever, chills, as well as shoulder pain and inflammation.
Pt exp erythema, edema & extreme pain @ inject site p/receiving Influenza virus vax; muscular pain also affected the trapezius muscles; not able to rotate head ten degrees in either direction secondary to pain & muscle spasm; Also fever;
Patient said her arm is sore and tender to the touch.  Her skin is usually soft but feels tight when she extends or relax her arms.  She said her pain have moved to her right bi-ceps.  She also said it is not noticable but lumpy.  She saw a nurse from work and the nurse said she may have a hematoma and the nurse told her to take Tylenol and hydrate.
directly after shot had a weird taste in my moth felt dizzy and nauseous severe cotton mouth , all but cotton mouth went away fairly qickly ok after that. 7pm that evening my  tongue at the sides of my back teeth hurt terribly and acquired a couple small cankersores,  felt very tired around this time and went to bed. 1am woke up with severe chills,body aches and nausea leftarm still VERY sore also feel "floaty/dizzy" mild headache and GI issues. Tried to work got sent home.. currently have all said symptoms  still but hasnt been quite 24 hrs
I did not see a doctor and I knew this was just a reaction. I had pain across top of shoulders that evening of 03/06/2021 around 6:30 PM. I was fatigued and a bit achy through the night and the following morning. I went to bed at noon and I was cold and had a fever. It was maybe around 101. I had muscle aches, back and neck aches. No congestion or stomach pain. I was very fatigued and I laid in bed all afternoon and took Tylenol because I can't take NSAIDS. I started feeling better in the evening 24 hours later. I was fatigued for the following 3-4 days and I felt like I was walking through mud and it was hard to move my leg, but  by Thursday I was fine. I also had sore left arm where injection site was.
Sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore left arm) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Sore left arm). At the time of the report, MYALGIA (Sore left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Passing of blood in urine; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD URINE PRESENT (Passing of blood in urine) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included Nephrectomy (kidney removal) on 26-Mar-2021. Concurrent medical conditions included Cancer.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLOOD URINE PRESENT (Passing of blood in urine). At the time of the report, BLOOD URINE PRESENT (Passing of blood in urine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Brief, tonic clonic activity commenced approx 3 hrs after administration of vaccines.  Seizure was preceded by a fever of at least 102.4, which began about one hour after vaccine given.  The child was not post-ictal, and was in good health on re-evaluation, about one hour after the seizure.
15min p/vax sniffling & coughing & then erythema of face w/some urticaria of trunk & limbs;wheeze heard in chest;med given;
This spontaneous report as received from a healthcare worker refers to a 12 month old female patient with sensitive skin. There were no drug reactions/allergies. On 09-OCT-2014 the patient was vaccinated with (Oka/Merck) VARIVAX (dose not reported, lot # reported as K005186, expired date: 10-APR-2016). Other suspect therapies included M-M-R II (dose not reported, lot # reported as J013131, expired date: 17-OCT-2016). Concomitant therapies included Vitamin D (unspecified). On 09-OCT-2014, 1 day onset of therapy the patient experienced hives below the injection sites of both vaccines. There was no treatment given for the event. There was no lab diagnostics studies performed. The outcome of hives below the injection sites of both vaccines was reported as recovering/resolving. The patient was still in the physician's office when the reaction occurred. Additional information has been requested.
Seizure immediately after third injection (meningococcal), lasting less than 1 minute. EMS called. Blood pressure spike, dropping to normal over several minutes. Blood sugar normal.
One hour post vax, the pt's experienced joint discomfort. 48 hours later a rash developed around lips.
Sudden onset of feeling flushed and burning sensation through face, neck, shoulders, back and arms. Immediately noticed a bright red rash that spread across my body from my head down to my feet. Tingling sensation in lips and tongue.   Self medicated with 50mg oral Benadryl.   Radiating heat from the rash subsided after about 1 hour, and the rash disapated over the next 3-4 hours with no recurrence.
Pain and redness - 4" x 2" area - located 1"-2" below injection site - (L) deltoid.
24 hrs after 3rd GARDASIL, pt. developed severe migraine that persisted for 5 days despite multiple medications (triptan, narcotics, ibuprofen, acetaminophen, then valproate).
Top of arm where shot waas administered has developed an itchy rash, is swollen, and hot to the touch.
Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023; No adverse event; She had expired vaccine that was administered on March 15,2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on March 15,2023), PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023) and NO ADVERSE EVENT (No adverse event) in a 38-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 060B22A) for COVID-19 prophylaxis.     It was unknown if the patient was ever diagnosed with/ tested positive for COVID-19.     On 15-Mar-2023, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 15-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on March 15,2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on March 15,2023), PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on March 15,2023) and PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023).    No concomitant medication details was reported.  Vial size was reported as 10 dose vial. The vial was initially stored in the refrigerator on 14-MAR-2023  The vial did not undergo any temperature excursions. It was reported that HCP states that expired Moderna COVID-19 monovalent vaccine was administered to approximately 75-125 patients on 15-MAR-2023. There was potentially a second lot number that was expired and was administered to patients on 3-MAR-2023, but HCP did not had any details on that event at the time of report. HCP wanted to know if the vaccine administered on 15-MAR-2023 would be considered valid for the patients.  No treatment medication details was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-716065 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716065:Master case
Itchy from head to toe within 30 minutes of administration. Gave 50 mg Benadryl by mouth. No additional doses needed-Patient F/U 10/25-felt fine
This spontaneous report as received from a pharmacy technician concerning a currently 16 years old adolescent. Gender was not reported. Medical history and concurrent conditions were not reported. On 15-APR-2014, the patient was vaccinated with VARIVAX (Merck) lot #J009165; expiration date: 24-JUL-2015, (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Patient was vaccinated with VARIVAX (Merck) that was exposed to 43.1 degrees F for 29 hours on 03-MAR-2014. This is one of several reports from the same reporter. Additional information has been requested.
Employee's left deltoid was red + swollen.  Redness measured 4cm, swelling measured 3-4 cm.
A few hours after 2nd COVID-19 vaccine, my daughter developed a facial twitch on her right check cheek. Her shot was administered in her left arm. It is day 5 and it is still there. She has had minor headaches for a few days, pain and swelling at site of shot. Day 3, she woke up with belly aches, headache, sore throat and chills (no temperature). This lasted about 24 hours.
Fever of 101 deg. F for three four days, seizures from fever (probably due to pre-existing brain condition), vomiting 3-4 times a day for four days, red bumps all over body that lasted for 6 days.
Patient received a expired vaccine 16Apr2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a expired vaccine 16Apr2022) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Patient height reported as unknown. Patient never had COVID positive test nor diagnosed. No Other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  Concurrent medical conditions included Kidney disorder, Diabetes, Hypertension and Allergy to antibiotic.    On 20-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a expired vaccine 16Apr2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a expired vaccine 16Apr2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported unknown for recent change in status such as improvement or worsening of each condition kidney disease, diabetes, and hypertension. No concomitant medication was reported.  Patient took second Booster on 20-Apr-2022.  It was unknown if adverse event cause patient to seek medical care (office visit, Urgent care, ER, hospitalized) and unknown if patient experienced a similar event in the past. No death occurred.  No treatment medication was reported.
RED FLAT LINE ON LEFT SIDE; ACHY; This spontaneous report received from a parent concerned a 27 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced red flat line on left side. On 10-APR-2021, the subject experienced achy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from red flat line on left side, and achy. This report was non-serious.
TIRED; LITTLE HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced tired, and little headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tired and little headache was not reported. This report was non-serious.